| Danny L Huynh, MD | |
|
2120 Truxtun Ave, Bakersfield, CA 93301 | |
| (661) 327-3638 | |
| (661) 327-2869 |
| Full Name | Danny L Huynh |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 13 Years |
| Location | 2120 Truxtun Ave, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356637698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2011018417 (Missouri) | Secondary |
| 208800000X | Urology | A142398 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Around The Clock Home Care | Bakersfield, CA | Home health agency |
| Adventist Health Bakersfield | Bakersfield, CA | Hospital |
| Kern Medical Center | Bakersfield, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health Physicians Network | 3274580972 | 499 |
| Kern County Hospital Authority | 4688964521 | 214 |
News Archive
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
Ever since the first cases of a mysterious disease in the early 1980s exploded into the HIV/AIDS pandemic, researchers have been searching for ways to outsmart the deadly virus.
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. The researchers found that the microbes block nitric oxide production by subverting the biochemical machinery used by immune cells called macrophages to produce the chemical.
A component of DNA that can both stimulate and suppress the immune system, depending on the dosage, may hold hope for treating cancer and infection, Medical College of Georgia researchers say.
› Verified 1 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
Ever since the first cases of a mysterious disease in the early 1980s exploded into the HIV/AIDS pandemic, researchers have been searching for ways to outsmart the deadly virus.
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. The researchers found that the microbes block nitric oxide production by subverting the biochemical machinery used by immune cells called macrophages to produce the chemical.
A component of DNA that can both stimulate and suppress the immune system, depending on the dosage, may hold hope for treating cancer and infection, Medical College of Georgia researchers say.
› Verified 1 days ago
| Entity Name | Kern County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623538 PECOS PAC ID: 4688964521 Enrollment ID: O20160915002690 |
News Archive
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
Ever since the first cases of a mysterious disease in the early 1980s exploded into the HIV/AIDS pandemic, researchers have been searching for ways to outsmart the deadly virus.
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. The researchers found that the microbes block nitric oxide production by subverting the biochemical machinery used by immune cells called macrophages to produce the chemical.
A component of DNA that can both stimulate and suppress the immune system, depending on the dosage, may hold hope for treating cancer and infection, Medical College of Georgia researchers say.
› Verified 1 days ago
| Entity Name | Complete Urology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275123242 PECOS PAC ID: 8325457096 Enrollment ID: O20210510001334 |
News Archive
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
Ever since the first cases of a mysterious disease in the early 1980s exploded into the HIV/AIDS pandemic, researchers have been searching for ways to outsmart the deadly virus.
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. The researchers found that the microbes block nitric oxide production by subverting the biochemical machinery used by immune cells called macrophages to produce the chemical.
A component of DNA that can both stimulate and suppress the immune system, depending on the dosage, may hold hope for treating cancer and infection, Medical College of Georgia researchers say.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny L Huynh, MD 2120 Truxtun Ave, Bakersfield, CA 93301-3703 Ph: (661) 327-3638 | Danny L Huynh, MD 2120 Truxtun Ave, Bakersfield, CA 93301 Ph: (661) 327-3638 |
News Archive
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen's preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
Ever since the first cases of a mysterious disease in the early 1980s exploded into the HIV/AIDS pandemic, researchers have been searching for ways to outsmart the deadly virus.
The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. The researchers found that the microbes block nitric oxide production by subverting the biochemical machinery used by immune cells called macrophages to produce the chemical.
A component of DNA that can both stimulate and suppress the immune system, depending on the dosage, may hold hope for treating cancer and infection, Medical College of Georgia researchers say.
› Verified 1 days ago
Soroush Bazargani, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Dr. Albert Mcbride, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-5590 Fax: 661-326-2282 | |
Dr. Bruce C Stone, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Stockdale Hwy Ste 109, Bakersfield, CA 93311 Phone: 661-664-4455 | |
Dr. Peter Reeves Mallen, M.D., FRCS(C), FACS Urology Medicare: Not Enrolled in Medicare Practice Location: 11606 Harrington St, Bakersfield, CA 93311 Phone: 661-665-2363 Fax: 661-663-7657 | |
Alan Cleveland Aikens, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2701 Chester Ave, 202, Bakersfield, CA 93301 Phone: 661-716-9410 Fax: 661-716-9415 | |
Dr. Robert L. Waguespack, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3550 Q St Ste 302, Bakersfield, CA 93301 Phone: 661-331-3303 Fax: 661-321-3308 | |
Dr. Michael Gerard Oefelein, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3941 San Dimas St Ste 103a, Bakersfield, CA 93301 Phone: 661-520-5010 Fax: 661-520-5020 |